Neurofilament light chain in the assessment of patients with multiple sclerosis
Open Access
- 1 June 2019
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 77 (6) , 436-441
Abstract
Multiple sclerosis (MS) is an autoimmune, inflammatory, and degenerative disease of the central nervous system. Axonal degeneration is triggered by inflammation and is the pathological substrate of progressive disability in patients with MS. Therapeutic interventions can reduce inflammatory activity, thus delaying neurodegeneration and the progression of disability. Disease activity and neurodegeneration are assessed mainly through clinical evaluation and magnetic resonance imaging. These measures lack sensitivity and accuracy, so new biomarkers are necessary. Several markers have been studied and to date the most promising is neurofilament light (NfL), a component of the axonal cytoskeleton, which is released into cerebrospinal fluid (CSF) following axonal damage. In the present study, we review the current knowledge about CSF NfL determination in MS, clinically isolated syndrome, and radiologically isolated syndrome, and critically discuss how CSF NfL measurement may contribute to therapeutic decision-making in these patients.Keywords
This publication has 41 references indexed in Scilit:
- Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological DiseasesPLOS ONE, 2013
- Serum and cerebrospinal fluid light neurofilaments and antibodies against them in clinically isolated syndrome and multiple sclerosisJournal of Neuroimmunology, 2013
- CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndromeMultiple Sclerosis Journal, 2012
- Protein biomarkers for multiple sclerosis: semi-quantitative analysis of cerebrospinal fluid candidate protein biomarkers in different forms of multiple sclerosisMultiple Sclerosis Journal, 2012
- Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumabAnnals of Neurology, 2010
- Prognostic Factors in Multiple Sclerosis2007
- Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and lossJournal of the Neurological Sciences, 2005
- The Relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosisJournal of Neurology, 2004
- Monoclonal Antibodies Selective for Low Molecular Weight NeurofilamentsHybridoma and Hybridomics, 2002
- Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1998